28.82
price up icon0.49%   0.14
pre-market  Vorhandelsmarkt:  28.81   -0.01   -0.03%
loading

Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten

pulisher
Dec 10, 2025

MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains - Seeking Alpha

Dec 10, 2025
pulisher
Dec 08, 2025

Certain Common Stock of MBX Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com

Dec 08, 2025
pulisher
Dec 06, 2025

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), MBX Biosciences, Inc. (MBX) and Praxis Precision Medicines (PRAX) - The Globe and Mail

Dec 06, 2025
pulisher
Dec 05, 2025

Goldman Sachs initiates coverage of MBX Biosciences (MBX) with sell recommendation - MSN

Dec 05, 2025
pulisher
Dec 04, 2025

Goldman Sachs Initiates Coverage of MBX Biosciences (MBX) with Sell Recommendation - Nasdaq

Dec 04, 2025
pulisher
Dec 04, 2025

MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM ExitWhat's Changed - Yahoo Finance

Dec 04, 2025
pulisher
Dec 04, 2025

Goldman Sachs initiates MBX Biosciences stock with Sell rating on platform concerns - Investing.com Nigeria

Dec 04, 2025
pulisher
Dec 04, 2025

Goldman Sachs initiates MBX Biosciences stock with Sell rating on platform concerns By Investing.com - Investing.com South Africa

Dec 04, 2025
pulisher
Dec 04, 2025

MBX Biosciences drops 4% in premarket trading after Goldman initiates with sell - MSN

Dec 04, 2025
pulisher
Dec 04, 2025

MBX Biosciences initiated with a sell at Goldman Sachs - MSN

Dec 04, 2025
pulisher
Dec 04, 2025

Goldman Sachs Initiates Coverage on MBX with Sell Rating | MBX S - GuruFocus

Dec 04, 2025
pulisher
Dec 04, 2025

Goldman Sachs Initiates Coverage on MBX Biosciences With Sell Rating, $18 Price Target - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

MBX Biosciences initiated with a Sell at Goldman Sachs - TipRanks

Dec 04, 2025
pulisher
Dec 04, 2025

Is MBX Biosciences Inc. stock attractive for growth ETFsJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones - Nasdaq

Dec 03, 2025
pulisher
Dec 03, 2025

Sio Capital Management LLC Acquires New Holdings in MBX Biosciences, Inc. $MBX - MarketBeat

Dec 03, 2025
pulisher
Dec 02, 2025

How MBX Biosciences Inc. stock benefits from global expansionGold Moves & Growth Focused Stock Pick Reports - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

MBX Biosciences (MBX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 02, 2025

MBX Biosciences (NASDAQ:MBX) Sets New 12-Month HighHere's What Happened - MarketBeat

Dec 02, 2025
pulisher
Dec 01, 2025

Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus - MSN

Dec 01, 2025
pulisher
Dec 01, 2025

How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6% - MSN

Dec 01, 2025
pulisher
Dec 01, 2025

MBX Biosciences, Inc. $MBX Shares Purchased by Franklin Resources Inc. - MarketBeat

Dec 01, 2025
pulisher
Nov 29, 2025

Rockefeller Capital Management L.P. Acquires Shares of 34,135 MBX Biosciences, Inc. $MBX - MarketBeat

Nov 29, 2025
pulisher
Nov 27, 2025

MBX Biosciences (NASDAQ:MBX) Trading Up 5.6%Should You Buy? - MarketBeat

Nov 27, 2025
pulisher
Nov 26, 2025

MBX S-8 & SEC Filings - Yahoo Finance Australia

Nov 26, 2025
pulisher
Nov 26, 2025

MBX Biosciences Advances Phase 2a Study on PBH Treatment with Imapextide - MSN

Nov 26, 2025
pulisher
Nov 25, 2025

Mbx biosciences stock reaches all-time high at 32.16 USD - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

Mbx biosciences stock reaches all-time high at 32.16 USD By Investing.com - Investing.com Australia

Nov 25, 2025
pulisher
Nov 24, 2025

MBX: Once-monthly obesity candidate MBX 4291 shows strong potential for best-in-class tolerability and efficacy - TradingView

Nov 24, 2025
pulisher
Nov 21, 2025

Will MBX Biosciences Inc. stock outperform tech sector in 2025Earnings Miss & Low Risk High Reward Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is MBX Biosciences Inc. stock a safe buy before earningsSell Signal & Precise Swing Trade Entry Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will MBX Biosciences Inc. stock rally after Fed decisionsTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 21, 2025
pulisher
Nov 21, 2025

MBX Biosciences stock maintains Buy rating at Jefferies on strong Phase 2 data By Investing.com - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 20, 2025

MBX Biosciences stock maintains Buy rating at Jefferies on strong Phase 2 data - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Can MBX Biosciences Inc. stock resist sector downturns - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will MBX Biosciences Inc. stock remain a Wall Street favorite2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

MBX: Strong clinical progress and funding position drive multiple catalysts in endocrine and metabolic pipeline - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

MBX: Strong clinical progress and funding drive late-stage catalysts in endocrine and metabolic programs - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

How rising interest rates impact MBX Biosciences Inc. stockQuarterly Performance Summary & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Chart based exit strategy for MBX Biosciences Inc.Recession Risk & Smart Swing Trading Techniques - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Visualizing MBX Biosciences Inc. stock with heatmapsQuarterly Growth Report & Consistent Profit Trading Strategies - newser.com

Nov 19, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):